drugset / Trial / NCT00050921

Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs

NCT00050921 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

This study is designed to evaluate the ability of growth hormone (GH, also known as somatropin) to increase CD4+ cell counts in patients taking anti-HIV drugs. The study is targeted toward patients with low levels of HIV who continue to have low CD4+ cell counts.

Timeline

Start
—
Primary completion
—
Completion
2005-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic — Subcutaneous
Background Hepatitis A Virus Vaccine — —
Background keyhole limpet hemocyanin Vaccine — —